China Life Insurance Co Ltd
China Life Insurance Co Ltd provides life and health insurance products and services in China and internationally.
Business. China Life Insurance Co Ltd (2628.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not provided.
Analyst recommendations
17 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
China Life Insurance Co Ltd (2628.HK) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific shifts in performance, strategy, or market position can be asserted based on the available data. The company’s current profile indicates a lean executive structure with only one officer on record, alongside a modest level of analyst coverage from nine analysts. It maintains membership in one index, though no top holders are currently identified in the dataset. Recent monitoring of cross-source signals reveals a period of minimal activity, with zero dispatches recorded daily from June 24 through July 11, 2026. A single dispatch was noted on July 12, 2026, but no sentiment data was attached to this event, and activity returned to zero in the subsequent days. Given the absence of material changes, watcher signals, or saga developments, the significance of this snapshot lies in establishing a baseline for future comparison. Investors and analysts should note that the current data reflects a static state with no reported volatility or notable corporate actions during the observed period.
Signals & dispatch
Composite-score breakdown
Synthesis
China Life Insurance Co Ltd (2628.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not provided.
China Life Insurance Co Ltd has a market capitalization of 218.92 billion CNY, with a market price of 29.42 CNY per share. The company has 7.44 billion shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and returns data are not available in the current snapshot, and no industry_config preferred metrics are provided for comparison. Analysts have assigned a mean price target of 33.47 CNY and a median price target of 33.05 CNY, indicating a generally positive outlook.
Segment and geographic exposure details are not disclosed in the available data. The company operates primarily in China and internationally, but specific revenue concentration by segment or region is not provided.
Growth trajectory is not quantified in the current data, but analyst estimates suggest a positive outlook with a mean recommendation of 1.71, indicating a strong buy to hold range.
Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and no going-concern language in source documents. Dilution risk is currently low, with no near-term pressure expected.
Recent events and filings are not detailed in the available data. Analysts have issued 6 strong-buy, 10 buy, and 1 hold recommendations, reflecting a generally optimistic sentiment.
China Life Insurance Co Ltd (2628.HK) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific shifts in performance, strategy, or market position can be asserted based on the available data. The company’s current profile indicates a lean executive structure with only one officer on record, alongside a modest level of analyst coverage from nine analysts. It maintains membership in one index, though no top holders are currently identified in the dataset. Recent monitoring of cross-source signals reveals a period of minimal activity, with zero dispatches recorded daily from June 24 through July 11, 2026. A single dispatch was noted on July 12, 2026, but no sentiment data was attached to this event, and activity returned to zero in the subsequent days. Given the absence of material changes, watcher signals, or saga developments, the significance of this snapshot lies in establishing a baseline for future comparison. Investors and analysts should note that the current data reflects a static state with no reported volatility or notable corporate actions during the observed period.
- Analysts have a generally positive outlook, with a mean price target of 33.47 CNY and a median price target of 33.05 CNY.
- The company has no dilution between basic and diluted shares, indicating stable capital structure.
- Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
- Analysts have issued 6 strong-buy, 10 buy, and 1 hold recommendations, reflecting a generally optimistic sentiment.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income +55,6% YoY; Net income +44,1% YoY.
- ▍Operating income +55,6% YoY
- ▍Net income +44,1% YoY
- ▍Free cash flow +48,0% YoY
Operating income +139,4% YoY; Net income +131,6% YoY.
- ▍Operating income +139,4% YoY
- ▍Net income +131,6% YoY
- ▍Free cash flow +180,4% YoY
Operating income −33,4% YoY; Net income −30,7% YoY.
- ▍Operating income −33,4% YoY
- ▍Net income −30,7% YoY
- ▍Free cash flow −33,5% YoY
Operating income +87,2% YoY; Net income +31,4% YoY.
- ▍Operating income +87,2% YoY
- ▍Net income +31,4% YoY
- ▍Free cash flow +54,4% YoY
Operating income ¥40.01B.
- ▍Operating income ¥40.01B
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 4,22 |
| Revenue | —no estimate | —no estimate | 232,8B CNY |
| Operating income | —no estimate | —no estimate | 187,4B CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- China Life Insurance Co Ltd Market data — financials · 2026-05-26
- China Life Insurance Co Ltd Market data — analyst estimates · 2026-05-26
Ownership & reference
Leadership
- Tao BaiExecutive Chairman of the Board